-
Something wrong with this record ?
Encapsulation of poorly soluble drugs in yeast glucan particles by spray drying improves dispersion and dissolution properties
G. Ruphuy, I. Saloň, J. Tomas, P. Šalamúnová, J. Hanuš, F. Štěpánek,
Language English Country Netherlands
Document type Journal Article
Grant support
NV16-27522A
MZ0
CEP Register
- MeSH
- Aerosols MeSH
- beta-Glucans chemistry isolation & purification MeSH
- Ibuprofen chemistry MeSH
- Kinetics MeSH
- Curcumin chemistry MeSH
- Drug Carriers * MeSH
- Drug Compounding MeSH
- Solubility MeSH
- Saccharomyces cerevisiae chemistry MeSH
- Ultrasonics * MeSH
- Drug Liberation MeSH
- Particle Size MeSH
- Desiccation * MeSH
- Publication type
- Journal Article MeSH
In this work, novel amorphous solid dispersions based on yeast glucan particles were produced. Yeast glucan particles are hollow and porous, and they are mainly composed of amorphous polysaccharides. We hypothesized that these particles are suitable candidates for the amorphization of drugs with low water solubility. Model drugs ibuprofen and curcumin were successfully encapsulated in glucan particles by spray drying. Different spray-drying parameters were tested to evaluate the influence of atomizing droplet size and initial solid content on encapsulation efficiency. It was shown that higher solid content and, more significantly, larger droplet sizes lead to higher encapsulation efficiencies. The encapsulation efficiency of ibuprofen (10 wt%) into glucan particles was considerably improved from 41.3 ± 0.5% to 64.3 ± 0.2% by increasing initial solid content and droplet size with the two-fluid nozzle. The spray drying process was further optimized by using the ultrasonic nozzle and it was possible to achieve complete encapsulation of ibuprofen and curcumin without any precipitation of the active compound outside of the glucan particles. Overall, it was possible to produce completely amorphous composites with outstanding wettability and dispersion properties, and with significantly faster dissolution rates when compared to the micronized crude drug.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc20028478
- 003
- CZ-PrNML
- 005
- 20210114154008.0
- 007
- ta
- 008
- 210105s2020 ne f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.ijpharm.2019.118990 $2 doi
- 035 __
- $a (PubMed)31899318
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a ne
- 100 1_
- $a Ruphuy, Gabriela $u Department of Chemical Engineering, University of Chemistry and Technology Prague, Technická 3, 166 28 Prague 6, Czech Republic. Electronic address: ruphuycg@vscht.cz.
- 245 10
- $a Encapsulation of poorly soluble drugs in yeast glucan particles by spray drying improves dispersion and dissolution properties / $c G. Ruphuy, I. Saloň, J. Tomas, P. Šalamúnová, J. Hanuš, F. Štěpánek,
- 520 9_
- $a In this work, novel amorphous solid dispersions based on yeast glucan particles were produced. Yeast glucan particles are hollow and porous, and they are mainly composed of amorphous polysaccharides. We hypothesized that these particles are suitable candidates for the amorphization of drugs with low water solubility. Model drugs ibuprofen and curcumin were successfully encapsulated in glucan particles by spray drying. Different spray-drying parameters were tested to evaluate the influence of atomizing droplet size and initial solid content on encapsulation efficiency. It was shown that higher solid content and, more significantly, larger droplet sizes lead to higher encapsulation efficiencies. The encapsulation efficiency of ibuprofen (10 wt%) into glucan particles was considerably improved from 41.3 ± 0.5% to 64.3 ± 0.2% by increasing initial solid content and droplet size with the two-fluid nozzle. The spray drying process was further optimized by using the ultrasonic nozzle and it was possible to achieve complete encapsulation of ibuprofen and curcumin without any precipitation of the active compound outside of the glucan particles. Overall, it was possible to produce completely amorphous composites with outstanding wettability and dispersion properties, and with significantly faster dissolution rates when compared to the micronized crude drug.
- 650 _2
- $a aerosoly $7 D000336
- 650 _2
- $a kurkumin $x chemie $7 D003474
- 650 12
- $a vysoušení $7 D003890
- 650 12
- $a nosiče léků $7 D004337
- 650 _2
- $a příprava léků $7 D004339
- 650 _2
- $a uvolňování léčiv $7 D065546
- 650 _2
- $a ibuprofen $x chemie $7 D007052
- 650 _2
- $a kinetika $7 D007700
- 650 _2
- $a velikost částic $7 D010316
- 650 _2
- $a Saccharomyces cerevisiae $x chemie $7 D012441
- 650 _2
- $a rozpustnost $7 D012995
- 650 12
- $a ultrazvuk $7 D014465
- 650 _2
- $a beta-glukany $x chemie $x izolace a purifikace $7 D047071
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Saloň, Ivan $u Department of Chemical Engineering, University of Chemistry and Technology Prague, Technická 3, 166 28 Prague 6, Czech Republic.
- 700 1_
- $a Tomas, Jan $u Department of Chemical Engineering, University of Chemistry and Technology Prague, Technická 3, 166 28 Prague 6, Czech Republic.
- 700 1_
- $a Šalamúnová, Petra $u Department of Chemical Engineering, University of Chemistry and Technology Prague, Technická 3, 166 28 Prague 6, Czech Republic.
- 700 1_
- $a Hanuš, Jaroslav $u Department of Chemical Engineering, University of Chemistry and Technology Prague, Technická 3, 166 28 Prague 6, Czech Republic.
- 700 1_
- $a Štěpánek, František $u Department of Chemical Engineering, University of Chemistry and Technology Prague, Technická 3, 166 28 Prague 6, Czech Republic.
- 773 0_
- $w MED00002359 $t International journal of pharmaceutics $x 1873-3476 $g Roč. 576, č. - (2020), s. 118990
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/31899318 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20210105 $b ABA008
- 991 __
- $a 20210114154005 $b ABA008
- 999 __
- $a ok $b bmc $g 1608813 $s 1119658
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2020 $b 576 $c - $d 118990 $e 20191230 $i 1873-3476 $m International journal of pharmaceutics $n Int. j. pharm. $x MED00002359
- GRA __
- $a NV16-27522A $p MZ0
- LZP __
- $a Pubmed-20210105